Medizinische Universität Graz - Research portal
Selected Publication:
Beitzke, A; Winter, R; Zach, M; Grubbauer, HM.
Congenital atrial flutter with hydrops fetalis caused by tocolytic therapy (author's transl)
Klin Padiatr. 1979; 191(4):410-417
Web of Science
PubMed
Google Scholar
- Co-authors Med Uni Graz
- Zach Maximilian
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Abstract:
- A 31-year-old healthy woman received Ritodrine (Pre-Par) from the 26th week of gestation because of twin pregnancy. Three weeks before birth continous intravenous medication with the same drug was commenced because of premature uterine contractions. Five days later a heart rate of over 200/minute was noted in one of the twins. This tachycardia persisted until birth while the heart rate of the other twin remained normal. At 33 weeks monozygotic female twins were delivered after artifical rupture of membranes. One twin was normal, birth weight 1.6 kg. The other baby showed persistent atrial flutter, was hydropic (weight 2.75 kg) and suffered from gross cardiac failure. Atrial flutter was converted to sinus rhythm one hour after birth by DC-countershock. Digoxin was commenced, the child rapidly improved and now still remains in sinus rhythm six month later.
- Find related publications in this database (using NLM MeSH Indexing)
- Atrial Flutter - chemically induced
- Digitalis Glycosides - therapeutic use
- Diseases in Twins - chemically induced
- Edema - chemically induced
- Female - chemically induced
- Heart Failure - drug therapy
- Humans - drug therapy
- Infant, Newborn - drug therapy
- Maternal-Fetal Exchange - drug therapy
- Obstetric Labor, Premature - prevention and control
- Pregnancy - prevention and control
- Prenatal Care - prevention and control
- Propanolamines - adverse effects
- Ritodrine - adverse effects
- Twins - adverse effects